LFM
BIIB icon

Lumina Fund Management’s Biogen BIIB Stock Holding History

Lumina Fund Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-600
Closed -$144K – 65
2021
Q4 		$144K Sell
600
-1,500
-71% -$386K 0.04% 38
2021
Q3 		$594K Hold
2,100
– – 0.21% 28
2021
Q2 		$727K Sell
2,100
-1,000
-32% -$303K 0.33% 22
2021
Q1 		$867K Hold
3,100
– – 0.33% 19
2020
Q4 		$759K Buy
+3,100
New +$800K 0.31% 20
2017
Q1 		– Sell
-29,600
Closed -$8.39M – 48
2016
Q4 		$8.39M Buy
29,600
+27,000
+1,038% +$8M 0.89% 7
2016
Q3 		$814K Hold
2,600
– – 0.09% 31
2016
Q2 		$629K Buy
+2,600
New +$685K 0.05% 29

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Lumina Fund Management's BIIB Position: Q1 2022 in Review

Lumina Fund Management sold out of Biogen (BIIB) in Q1 2022, closing a stake of 600 shares — an estimated $144K sold.

Lumina Fund Management first reported a position in BIIB in Q2 2016 and held it in 8 quarters. The position peaked at $8.39M in Q4 2016. 951 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • Lumina Fund Management reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
  • Lumina Fund Management sold 600 Biogen shares in Q1 2022, an estimated $144K.
  • Lumina Fund Management first reported a position in Biogen in Q2 2016 and held it in 8 quarters.
  • Lumina Fund Management's Biogen position peaked at $8.39M in Q4 2016.
  • 951 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Lumina Fund Management's 13F filing for Q1 2022, filed 13 May 2022.